Regeneron Pharmaceuticals’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Leonard S. Schleifer Thank you, Michael, and good morning to everyone. 2013 was another great year for Regeneron. The EYLEA franchise continue to grow steadily in the U.S. and globally our late-stage pipeline … more

View todays social media effects on REGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Regeneron is hiring next, click here to view